发明名称 |
COMPRESSED TABLETS COMPRISING VALSARTAN |
摘要 |
The invention is directed to compressed tablets comprising valsartan, microcrystalline cellulose and optionally crospovidone. The weight ratio of the valsartan to the microcrystalline cellulose is from 2:1 to 0.3:1. The microcrystalline cellulose can comprise more than 30% by weight based on total weight of the core of the tablet. The tablet is an oral dosage form for administration of the valsartan.
|
申请公布号 |
CA2622805(C) |
申请公布日期 |
2011.05.10 |
申请号 |
CA19992622805 |
申请日期 |
1999.12.22 |
申请人 |
NOVARTIS AG |
发明人 |
BULLOCK, GILLIAN ROSEMARY;DE GASPARO, MARC;GANTER, SABINA MARIA |
分类号 |
A61K31/41;A61K9/20;A61K9/28;A61K31/00;A61K31/415;A61K31/4178;A61K31/4188;A61K31/437;A61K31/44;A61K31/4439;A61K31/455;A61K45/00;A61K47/32;A61K47/38;A61P1/18;A61P9/12;A61P11/00;A61P11/06;A61P17/02;A61P35/00 |
主分类号 |
A61K31/41 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|